‘Intriguing’ results for Oxford vaccine
A coronavirus vaccine jointly developed by the University of Oxford and drug giant AstraZeneca has shown an “average efficacy of 70 per cent” in early trials and could be rolled out later this year if approved. “This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate… Read More »